Backs FY24 revenue view $67.75B-$70.25B, consensus $69.12B. The company said, “The Company’s 2024 guidance contains a number of assumptions, including, among others, the Company’s current expectations regarding patient volumes and payor mix as well as general economic conditions, including inflation, and excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claims costs and impairment of long-lived assets.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- Options Volatility and Implied Earnings Moves Today, April 26, 2024
- Catheter Precision receives first purchase order for LockeT from HCA Healthcare
- Augmedix announces general availability of Augmedix Go
- HCA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Early notable gainers among liquid option names on April 19th
